Literature DB >> 3806417

Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.

A Abas, P J Meffin.   

Abstract

The disposition of ketoprofen enantiomers has been studied in 12 rabbits with normal renal function (control) and in 6 of these rabbits with renal dysfunction. In control animals a mean (S.E.M.) of 0.09 (0.01) of R-ketoprofen was inverted to its S-enantiomer. The mean distribution volumes for R- and S-ketoprofen were 114 (7.4) and 294 (76) ml/kg, respectively. The mean clearance of the R-enantiomer from plasma was 292 (40) ml/kg/hr compared to 36 (3.2) ml/kg/hr for the S-enantiomer. This high degree of enantioselectivity was not due to inversion, renal clearance or clearance by glucuronidation, but was the result of an unknown clearance process(es). Comparing the mean parameters of ketoprofen disposition in renal dysfunction with those in the same animals during the control study, the mean fraction of the R-dose inverted increased by 290%, but this effect was not due to decreased clearance of R-ketoprofen renally or by glucuronidation. The distribution volumes of R- and S-ketoprofen were increased by 200 and 183% by renal dysfunction, consistent with an implied decrease in plasma protein binding. The clearances of bound plus unbound R- and S-ketoprofen from plasma remained unaltered by renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3806417

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

Review 1.  Stereoselectivity in clinical pharmacokinetics and drug development.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Pharmacokinetic parameters of (R)-(-) and (S)-(+)-flurbiprofen in dairy bovines.

Authors:  L Igarza; A Soraci; N Auza; H Zeballos
Journal:  Vet Res Commun       Date:  2006-07       Impact factor: 2.459

Review 3.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 4.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 5.  Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs.

Authors:  F Jamali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

6.  Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination.

Authors:  N G Grubb; D W Rudy; D C Brater; S D Hall
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

7.  The disposition of ketoprofen enantiomers in man.

Authors:  B C Sallustio; Y J Purdie; A G Whitehead; M J Ahern; P J Meffin
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

8.  Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans.

Authors:  H Cheng; J D Rogers; J L Demetriades; S D Holland; J R Seibold; E Depuy
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

9.  Chiral inversion of (R)-(-)-fenoprofen in guinea-pigs pretreated with clofibrate.

Authors:  M F San Martín; A Soraci; F Fogel; O Tapia; S Islas
Journal:  Vet Res Commun       Date:  2002-06       Impact factor: 2.459

Review 10.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.